Matinas BioPharma Holdings MTNB
NYSE MTNB
$1.13 -0.10 (-8.13%)
As of: Nov 11, 2026 · 11:59 AM EST

Matinas BioPharma Holdings (MTNB) Return on Equity [ROE] (2014 - 2026)

Updated

Matinas BioPharma Holdings (MTNB) posted Return on Equity [ROE] of -276.57% for Q2 2026, down 38.01 percentage points from -238.55% a year earlier and down 99.54 percentage points from the prior quarter.

Analysis

Matinas BioPharma Holdings (MTNB) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Matinas BioPharma Holdings' Return on Equity [ROE] came in at -166.59%, up 14.15 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -116.56 percentage points (FY2020 to FY2025).
  • In prior years, Matinas BioPharma Holdings' Return on Equity [ROE] was -180.73% in FY2024 (-98.63 pp), -82.11% in FY2023 (-26.93 pp), -55.18% in FY2022 (-12.61 pp) and -42.56% in FY2021 (+7.46 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • On a year-over-year basis, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -35.65 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2026, with a gain of 120.74 percentage points; the weakest was Q1 2025, with a drop of 155.28 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -177.02% (Q1 2026), -123.29% (Q4 2025) and -195.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Matinas BioPharma Holdings 508,224.03 -12.08 Mn - -287.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -287.64%
Mar 31, 2026 -270.63%
Dec 31, 2025 -183.26%
Sep 30, 2025 -238.64%
Jun 30, 2025 -280.50%
Mar 31, 2025 -287.86%
Dec 31, 2024 -205.66%
Sep 30, 2024 -119.10%
Jun 30, 2024 -133.38%
Mar 31, 2024 -134.85%
Dec 31, 2023 -105.38%
Sep 30, 2023 -81.12%
Jun 30, 2023 -67.56%
Mar 31, 2023 -59.19%
Dec 31, 2022 -57.61%
Sep 30, 2022 -61.05%
Jun 30, 2022 -57.66%
Mar 31, 2022 -49.60%
Dec 31, 2021 -44.67%
Sep 30, 2021 -40.46%
API Access

Matinas BioPharma Holdings Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEY